Latest Breaking News On - Orphan drug exclusivity - Page 6 : comparemela.com

Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter.

United statesRobert andradeLindsay roccoElixir health public relationsFennec pharmaceuticalsOregon healthFennec pharmaceuticals incScience universityWebcast detailEvent calendarEuropean commission marketing authorizationOrphan drug exclusivityPediatric use marketing authorization

Avadel Pharma (AVDL) Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023

Avadel Pharma (AVDL) Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rio de janeiroEstado do rioAkinyemio ajayiClete kushidaYves dauvilliersMichaelj thorpyLois krahnJennifer gudemanAnne marie morseLuise ortizCletea kushidaDepartment of psychiatryDepartment of neurologyWake disorders center at montefioreHuman sleep research at stanford universityClinical affairs of avadel

Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep.

United statesRio de janeiroEstado do rioLogan schneiderAndrean flynnKristin bhavnaniRob iannoneOnset rapid eye movement periodsJazz pharmaceuticalsHead of global corporate communicationsIdiopathic hypersomnia total health modelUnmet public health problemAmerican academy of sleep medicineNational academies pressStanford va alzheimer centerJazz pharmaceuticals inc

Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were.

United statesUniversity of south carolinaSouth carolinaRichardk boganAndrean flynnKelvin tanKristin bhavnaniPsych congressWorld idiopathic hypersomnia total health modelUnmet public health problemIndian journal of medical researchAmerican psychiatric associationNational health serviceNational institute of neurological disordersAmerican academy of sleep medicineHead of global corporate communications

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming.

United statesNew yorkRobert andradeLindsay roccoFennec pharmaceuticals incOregon healthElixir health public relationsEuropean commission marketing authorizationScience universityCompany presentationClinical oncology groupDrug administrationExchange commissionFennec pharmaceuticalsGlobal investment conferenceCantor fitzgerald global healthcare conference